Kevin C. Johnson - Jun 2, 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Kevin C. Johnson
Stock symbol
NEO
Transactions as of
Jun 2, 2021
Transactions value $
$0
Form type
4
Date filed
6/4/2021, 07:58 PM
Next filing
Dec 23, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +3.08K +9.94% $0.00 34.1K Jun 2, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Options (Right to Buy) Award $0 +3.71K $0.00 3.71K Jun 2, 2021 Common Stock 3.71K $40.90 Direct
holding NEO Stock Options (Right to Buy) 3.33K Jun 2, 2021 Common Stock 3.33K $7.27 Direct F1
holding NEO Stock Options (Right to Buy) 4.27K Jun 2, 2021 Common Stock 4.27K $22.52 Direct
holding NEO Stock Options (Right to Buy) 3.45K Jun 2, 2021 Common Stock 3.45K $28.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.